Cypher: Post-marketing study started

Johnson & Johnson's Cordis Corp. subsidiary began the double-blind, U.S. Phase IV CYPRESS trial to evaluate its Cypher sirolimus-eluting coronary stent in about 2,000 patients undergoing percutaneous...